Low-dose lacosamide-induced atrial fibrillation: Case analysis with literature review()()

Lacosamide (LCM) is a novel antiepileptic drug (AED) approved by the FDA for adjunctive treatment of partial epilepsy with and without secondary generalization. Lacosamide dose-dependent dysrhythmias (PR-interval prolongation, AV block, and atrial fibrillation/flutter) have been reported. This case...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaufman, Kenneth R., Velez, Arnaldo E., Wong, Stephen, Mani, Ram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4150593/
https://www.ncbi.nlm.nih.gov/pubmed/25688049
http://dx.doi.org/10.1016/j.ebcr.2012.10.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4150593/
https://www.ncbi.nlm.nih.gov/pubmed/25688049
http://dx.doi.org/10.1016/j.ebcr.2012.10.006

Ejemplares similares